- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | SciBase Partners with Al Shirawi Healthcare solutions to Offer Nevisense in UAE | 139 | PR Newswire | STOCKHOLM, April 24, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders is pleased to announce... ► Artikel lesen | |
| Di | SciBase will present at the Redeye Medtech Event on April 24th | 154 | PR Newswire | STOCKHOLM, April 23, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders will participate at... ► Artikel lesen | |
| Di | SciBase will present at the Redeye Medtech Event on April 24[th] | 2 | Cision News | ||
| Di | Today is the first day of the subscription period in SciBase rights issue | 163 | PR Newswire | STOCKHOLM, April 23, 2024 /PRNewswire/ -- Today, 23 April 2024, the subscription period in SciBase Holding AB (publ) ('SciBase' or the 'Company') rights issue of units of up to approximately... ► Artikel lesen | |
| Mo | Nasdaq Stockholm AB: Listing of paid subscription units of Scibase Holding AB | 150 | GlobeNewswire | With effect from April 23, 2024, the paid subscription units in Scibase Holding
AB will be traded on First North Growth Market. Trading will continue until and
including May 27, 2024.
Instrument:... ► Artikel lesen | |
| 19.04. | SciBase publishes prospectus in connection with upcoming rights issue | 168 | PR Newswire | STOCKHOLM, April 19, 2024 /PRNewswire/ -- On 5 April 2024, SciBase Holding AB (publ) ("SciBase" or the "Company") announced that the Board of Directors, with the support of the authorization... ► Artikel lesen | |
| 17.04. | XFRA CAPITAL ADJUSTMENT INFORMATION - 17.04.2024 | 347 | Xetra Newsboard | Das Instrument BO6 SE0014583332 BOMILL AB EQUITY wird cum Kapitalmassnahme gehandelt am 17.04.2024 und ex Kapitalmassnahme am 18.04.2024 The instrument BO6 SE0014583332 BOMILL AB EQUITY is traded cum... ► Artikel lesen | |
| 08.04. | Notice to extraordinary general meeting in Scibase Holding AB (publ) | 193 | PR Newswire | STOCKHOLM, Sweden, April 8, 2024 /PRNewswire/ -- Shareholders of SciBase Holding AB (publ), reg. no. 556773-4768 (the "Company"), are hereby summoned to an extraordinary general meeting to... ► Artikel lesen | |
| 08.04. | XFRA 5J3: WIEDERAUFNAHME/RESUMPTION | 153 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| 05.04. | SciBase resolves on a directed issue of approximately SEK 33 million and a rights issue of approximately SEK 15 million | 277 | PR Newswire | STOCKHOLM, April 5, 2024 /PRNewswire/ -- The Board of Directors SciBase Holding AB (publ) ("SciBase" or the "Company") has today resolved on a capital raise totaling approximately SEK 48... ► Artikel lesen | |
| 05.04. | Nasdaq Stockholm AB: Lift of Suspension in Scibase Holding AB at FNSE | 147 | GlobeNewswire | Lifting of Suspension
At Trading Venue FNSE
Issuer: Scibase Holding AB, LEI:549300IY6ZWVN0V2P455
--------------------------------------------------------------------------------
Instruments:... ► Artikel lesen | |
| 05.04. | XFRA 5J3: AUSSETZUNG/SUSPENSION | 87 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILSCIBASE HOLDING... ► Artikel lesen | |
| 28.02. | SciBase Partners with Skinobs to Offer Nevisense on Global Cosmetic Testing Platform | 276 | PR Newswire | STOCKHOLM, Feb. 28, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders is pleased to announce... ► Artikel lesen | |
| 21.02. | SciBase: Year-end report | 234 | PR Newswire | January 1 - December 31, 2023
STOCKHOLM, Feb. 21, 2024 /PRNewswire/ --
The fourth quarter in figures
Net sales were TSEK 5,764 (4,962), +16%.The loss after tax was TSEK 20... ► Artikel lesen | |
| 19.02. | SciBase: Keynote speakers presented Nevisense at the 2024 Winter Clinical Dermatology Conference in Miami | 837 | PR Newswire | STOCKHOLM, Feb. 19, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") [STO: SCIB], a leading developer of augmented intelligence-based solutions for skin disorders participated at the 2024... ► Artikel lesen | |
| 16.02. | SciBase: New study shows Nevisense evaluates skin barrier function with less sensitivity to lifestyle factors than TEWL | 349 | PR Newswire | STOCKHOLM, Feb. 16, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO:SCIB), a leading developer of augmented intelligence-based solutions for skin disorders announced today the publication... ► Artikel lesen | |
| 30.01. | SciBase initiates collaboration with Inderes for commissioned research | 577 | PR Newswire | STOCKHOLM, Jan. 30, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a pioneer in early detection and prevention in dermatology initiates cooperation with Inderes (www.inderes.se)... ► Artikel lesen | |
| 25.01. | Welcome to SciBase Capital Markets Day 2024 | 271 | PR Newswire | STOCKHOLM, Jan. 25, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") [STO: SCIB], a pioneer in early detection and prevention in dermatology hereby invites investors, analysts, and financial... ► Artikel lesen | |
| 19.01. | Reminder: Welcome to SciBase Capital Markets Day 2024 | 324 | PR Newswire | STOCKHOLM, Jan. 19, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a pioneer in early detection and prevention in dermatology hereby invites investors, analysts, and financial... ► Artikel lesen | |
| 10.01. | SciBase: Letter from the CEO | 282 | PR Newswire | STOCKHOLM, Jan. 10, 2024 /PRNewswire/ -- In my initial 100 days as CEO, I have been creating a roadmap for SciBase's rapid transition into a robust commercial company. I am impressed by the... ► Artikel lesen |
Seite:
1 2 Weiter >>
37 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ROKU | 58,65 | +0,20 % | Netflix Keeps Crashing on Roku TV | ||
| SERNOVA | 0,289 | -0,96 % | Sernova begrüßt den von Evotec nominierten Dr. Bernd Mühlenweg in seinem Board of Directors | - Dr. Daniel Mahony tritt von seinem Posten zurück, um sich neuen Aufgaben zu widmen
LONDON, ONTARIO; BOSTON, MASSACHUSETTS, den 22. April 2024 / IRW-Press / - Sernova Corp.... ► Artikel lesen | |
| PAUL HARTMANN | 212,00 | +0,47 % | Aktuell zu Ihren Aktien: Funkwerk, Paul Hartmann | Seit rund zwei Jahren ist mit der früher so gut laufenden Funkwerk-Aktie an der Börse nicht mehr viel los. Angesichts der Kursflaute wurde der Titel des in den Bereichen Funksysteme für den Bahnverkehr... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 68,00 | -0,73 % | ROUNDUP: Boston Scientific Boosts FY24 Outlook | WASHINGTON (dpa-AFX) - While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales... ► Artikel lesen | |
| INVIVO THERAPEUTICS HOLDINGS | 0,318 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 23.02.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 23.02.2024.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 23.02.2024.ISIN NameCA58503M4083 MEDIVOLVE... ► Artikel lesen | |
| ADDLIFE | 8,875 | +5,03 % | AddLife AB: Year-end report 1 January - 31 December 2023 | Strong cash flow and significant actions to improve profitability within Medtech
"Demand is healthy in the markets and segments where AddLife's companies operate. We can now summarize 2023 as a... ► Artikel lesen | |
| R1 RCM | 10,900 | +0,93 % | Coliseum Capital Issues Open Letter to Board of R1 RCM on Offer by New Mountain to Acquire the Company for $13.75 Per Share | ROWAYTON, Conn.--(BUSINESS WIRE)--Coliseum Capital Management, LLC ("Coliseum"), one of the largest shareholders of R1 RCM Inc. (NASDAQ: RCM) ("Company"), today announced that it has issued an... ► Artikel lesen | |
| EMBECTA | 9,800 | +1,03 % | Embecta Corp.: embecta to Report Fiscal Second Quarter 2024 Financial Results | ||
| ENOVIS | 51,50 | 0,00 % | Enovis Corporation: Enovis Announces Fourth Quarter and Full Year 2023 Results | Continued strong momentum with fourth-quarter sales growth of 11%, organic growth of 8% Reported fourth-quarter net income from continuing operations of $0.05 per share with adjusted earnings per... ► Artikel lesen | |
| SYSMEX | 15,200 | 0,00 % | Dividendenbekanntmachungen (28.03.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACOM CO LTD JP3108600002 6 JPY 0,0366 EUR ADVANEX INC JP3213400009 20 JPY 0,1222 EUR AICA KOGYO CO LTD JP3100800006 59 JPY 0... ► Artikel lesen | |
| PULMONX | 6,850 | -2,14 % | Pulmonx Corporation: Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer | REDWOOD CITY, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced... ► Artikel lesen | |
| KANGJI MEDICAL | 0,840 | 0,00 % | KANGJI MEDICAL (09997): FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING | ||
| SI-BONE | 13,700 | -2,14 % | SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance | SANTA CLARA, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported... ► Artikel lesen | |
| REVITALIST LIFESTYLE AND WELLNESS | 0,015 | 0,00 % | Revitalist Lifestyle and Wellness Ltd: Revitalist Lifestyle appoints president, director | ||
| PEIJIA MEDICAL | 0,435 | 0,00 % | XFRA 4WO: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILPEIJIA MEDICAL HD... ► Artikel lesen |
Das Unternehmen SCIBASE HOLDING AB kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,016 Euro und damit +254,55 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
